LOI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 2.068
EU - Europa 691
AS - Asia 367
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 3.130
Nazione #
US - Stati Uniti d'America 2.058
IE - Irlanda 208
HK - Hong Kong 170
IT - Italia 169
SE - Svezia 131
CN - Cina 103
PL - Polonia 86
JO - Giordania 59
DE - Germania 24
RU - Federazione Russa 22
GB - Regno Unito 20
SG - Singapore 15
IN - India 11
FI - Finlandia 10
CA - Canada 9
VN - Vietnam 6
ES - Italia 5
FR - Francia 5
CH - Svizzera 3
UA - Ucraina 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
AT - Austria 1
BR - Brasile 1
GL - Groenlandia 1
JP - Giappone 1
NG - Nigeria 1
PH - Filippine 1
TH - Thailandia 1
Totale 3.130
Città #
Fairfield 285
Chandler 248
Dublin 208
Ashburn 202
Seattle 148
Dearborn 141
Woodbridge 141
Cambridge 128
Hong Kong 122
Houston 116
Wilmington 101
Warsaw 86
Lawrence 47
Florence 43
Altamura 42
Beijing 41
Princeton 40
Ann Arbor 39
Buffalo 31
New York 28
San Diego 26
Shanghai 24
Moscow 20
Boston 19
Medford 19
West Jordan 11
Nanjing 10
Falls Church 8
Pune 8
London 7
Dong Ket 6
Toronto 6
Barcelona 5
Boardman 5
Hillsboro 5
Norwalk 5
Frankfurt am Main 4
Hefei 4
Kunming 4
Garden City 3
Guangzhou 3
Kent 3
Los Angeles 3
Pistoia 3
Rome 3
Singapore 3
Bern 2
Brussels 2
Busto Arsizio 2
Calgary 2
Chongqing 2
Empoli 2
Falkenstein 2
Fiesole 2
Helsinki 2
Kilburn 2
Milan 2
Nagold 2
Palombara Sabina 2
Prato 2
Redwood City 2
Romainville 2
Scarperia e San Piero 2
Southwark 2
Sydney 2
Wandsworth 2
Washington 2
Wuhan 2
Wuxi 2
Acton 1
Andover 1
Berlin 1
Bologna 1
Bracknell 1
Brentford 1
Brescia 1
Cabanatuan City 1
Castelliri 1
Cedar Knolls 1
Changchun 1
Changsha 1
Delhi 1
Fremont 1
Fuzhou 1
Gate City 1
Gorgonzola 1
Hebei 1
Hyderabad 1
Jinan 1
Kumar 1
Lagos 1
Lucca 1
Montemurlo 1
New Bedfont 1
Nuuk 1
Nürnberg 1
Phoenix 1
Pisa 1
Ponte Buggianese 1
Prague 1
Totale 2.531
Nome #
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 154
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 114
Influence of age and subtype in outcome of operable liposarcoma 114
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 113
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 112
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 111
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 110
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 103
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 98
Radiotherapy in the age of cancer immunology: Current concepts and future developments 96
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 96
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 95
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 94
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 91
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 89
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 88
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 86
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 85
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 85
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 81
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 79
Cancer stem cells: biology and potential therapeutic applications 78
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 70
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 65
Prognostic impact of nodal relapse in definitive prostate-only irradiation 64
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 42
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 42
Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors 42
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 41
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 38
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 38
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 35
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 33
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 32
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 30
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 29
Artificial Intelligence in radiotherapy: state of the art and future directions 25
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 24
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 24
Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy 23
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 22
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 22
Update chemotherapy schedule in the treatment of lung cancer 21
Lobectomy vs Stereotactic Ablative Radiotherapy in NSCLC: a multicentric series in four centers 21
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 20
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 19
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma 18
Chest wall resection and reconstruction for lung cancer: Surgical techniques and example of integrated multimodality approach 18
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 18
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 18
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 18
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 18
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 17
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 16
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 15
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 12
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 10
Single-fraction radiotherapy (SFRT) for bone metastases: Patient selection and perspectives 10
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 9
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 8
Totale 3.199
Categoria #
all - tutte 13.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 0 75 76
2019/2020862 36 25 6 58 134 168 154 94 86 51 40 10
2020/2021312 29 17 14 62 19 15 9 22 33 38 32 22
2021/2022253 5 13 17 26 6 16 9 26 10 9 43 73
2022/2023961 60 175 50 31 85 175 128 74 133 2 29 19
2023/2024513 20 46 63 26 40 84 36 158 8 29 3 0
Totale 3.199